Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

1.7K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.7K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

738
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
738
Direct-Acting Cholinergic Agonists: Pharmacological Actions00:59

Direct-Acting Cholinergic Agonists: Pharmacological Actions

2.5K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.5K
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

1.9K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.9K
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

2.0K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
2.0K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

2.3K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cortico-striatal action control inherent of opponent cognitive-motivational styles.

eLife·2025
Same author

Cortico-striatal action control inherent of opponent cognitive-motivational styles.

bioRxiv : the preprint server for biology·2024
Same author

Neuro-Immune Modulation of Cholinergic Signaling in an Addiction Vulnerability Trait.

eNeuro·2023
Same author

Basal Forebrain Chemogenetic Inhibition Converts the Attentional Control Mode of Goal-Trackers to That of Sign-Trackers.

eNeuro·2023
Same author

Cholinergic systems, attentional-motor integration, and cognitive control in Parkinson's disease.

Progress in brain research·2022
Same author

Disrupted Choline Clearance and Sustained Acetylcholine Release <i>In Vivo</i> by a Common Choline Transporter Coding Variant Associated with Poor Attentional Control in Humans.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2022

Related Experiment Video

Updated: Feb 28, 2026

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

10.3K

Behavioral-Cognitive Targets for Cholinergic Enhancement.

Martin Sarter1

  • 1University of Michigan, Department of Psychology, 4030 East Hall, 530 Church Street, Ann Arbor, MI 48109.

Current Opinion in Behavioral Sciences
|June 14, 2017
PubMed
Summary
This summary is machine-generated.

Cholinergic mechanisms, involving transient spikes and neuromodulation, enhance cognitive functions like attention and task compliance. Stimulating specific nicotinic acetylcholine receptors may improve attentional performance in brain disorders.

More Related Videos

Touchscreen Sustained Attention Task SAT for Rats
09:31

Touchscreen Sustained Attention Task SAT for Rats

Published on: September 15, 2017

10.4K
Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine
10:48

Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine

Published on: January 25, 2019

9.8K

Related Experiment Videos

Last Updated: Feb 28, 2026

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
07:02

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development

Published on: February 11, 2019

10.3K
Touchscreen Sustained Attention Task SAT for Rats
09:31

Touchscreen Sustained Attention Task SAT for Rats

Published on: September 15, 2017

10.4K
Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine
10:48

Probing Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices via Laser Flash Photolysis of Photoactivatable Nicotine

Published on: January 25, 2019

9.8K

Area of Science:

  • Neuroscience
  • Cognitive Science
  • Pharmacology

Background:

  • Cholinergic mechanisms are key targets for cognitive enhancement.
  • Two components of cholinergic activity, transient spikes and neuromodulation, are proposed to mediate distinct cognitive functions.
  • Transient cholinergic activity aids cue detection during attentional shifts, while neuromodulation supports task compliance under performance challenges.

Purpose of the Study:

  • To explore the role of cholinergic activity in cognitive functions.
  • To investigate the interaction between cholinergic components and their impact on attention and task compliance.
  • To identify potential therapeutic targets within the cholinergic system for cognitive disorders.

Main Methods:

  • The study proposes a theoretical framework based on existing literature.
  • It focuses on the proposed mechanisms of cholinergic action.
  • It highlights the role of alpha4beta2* nicotinic acetylcholine receptors.

Main Results:

  • Increases in cholinergic neuromodulation enhance cholinergic transients.
  • Stimulation of alpha4beta2* nicotinic acetylcholine receptors stabilizes attention and improves cue detection.
  • These effects suggest a mechanism for improving cognitive deficits.

Conclusions:

  • Cholinergic neuromodulation and transients play distinct roles in cognitive functions.
  • Alpha4beta2* nicotinic acetylcholine receptor stimulation shows promise for enhancing attentional performance.
  • Adjunctive treatments targeting these receptors could benefit individuals with unstable attention and low cue detection rates in brain disorders.